Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Treatment Continuation Study for Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease Who Have Successfully Complete Study CMD-2019-001

NCT04313166 is registered in ClinicalTrials.gov with Collaborative Medicinal Development Pty Limited as lead sponsor.

NCT NCT04313166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04313166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Treatment Continuation Study for Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease Who Have Successfully Complete Study CMD-2019-001
Lead sponsor
Collaborative Medicinal Development Pty Limited
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2020
Completion date
February 15, 2022
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis